Hubble Space Telescope/WFPC2 Investigation of the Nuclear Morphology in the Toomre Sequence of Merging Galaxies

We report on the properties of nuclear regions in the Toomre Sequence of merging galaxies, based on imaging data gathered with the Hubble Space Telescope WFPC2 camera. We have imaged the 11 systems in the proposed evolutionary merger sequence in the F555W and F814W broad-band filters, and in H-alpha+[NII] narrow-band filters. The broad-band morphology of the nuclear regions varies from non-nucleated starburst clumps through dust-covered nuclei to a nucleated morphology. There is no unambiguous trend in the morphology with merger stage. The emission-line morphology is extended beyond the nucleus in most cases, but centrally concentrated (within 1 kpc) emission-line gas can be seen in the four latest-stage merger systems. We have quantified the intrinsic luminosity densities and colors within the inner 100 pc and 1 kpc of each identified nucleus. We find little evidence for a clear trend in nuclear properties along the merger sequence, other than a suggestive rise in the nuclear luminosity density in the most evolved members of the sequence. The lack of clear trends in nuclear properties is likely due both to the effects of obscuration and geometry, as well as the physical variety of galaxies included in the Toomre Sequence.Comment: LaTeX, 24 pages, 21 figures, 2 tables, accepted for publication in The Astronomical Journal, paper with high resolution figures can be accessed at http://www.stsci.edu/~marel/psgzdir/toomreWFPC2.ps.g

The Role of Hospital Inpatients in Supporting Medication Safety: A Qualitative Study.

BACKGROUND:Inpatient medication errors are a significant concern. An approach not yet widely studied is to facilitate greater involvement of inpatients with their medication. At the same time, electronic prescribing is becoming increasingly prevalent in the hospital setting. In this study we aimed to explore hospital inpatients' involvement with medication safety-related behaviours, facilitators and barriers to this involvement, and the impact of electronic prescribing. METHODS:We conducted ethnographic observations and interviews in two UK hospital organisations, one with established electronic prescribing and one that changed from paper to electronic prescribing during our study. Researchers and lay volunteers observed nurses' medication administration rounds, pharmacists' ward rounds, doctor-led ward rounds and drug history taking. We also conducted interviews with healthcare professionals, patients and carers. Interviews were audio-recorded and transcribed. Observation notes and transcripts were coded thematically. RESULTS:Paper or electronic medication records were shown to patients in only 4 (2%) of 247 cases. However, where they were available during patient-healthcare professional interactions, healthcare professionals often viewed them in order to inform patients about their medicines and answer any questions. Interprofessional discussions about medicines seemed more likely to happen in front of the patient where paper or electronic drug charts were available near the bedside. Patients and carers had more access to paper-based drug charts than electronic equivalents. However, interviews and observations suggest there are potentially more significant factors that affect patient involvement with their inpatient medication. These include patient and healthcare professional beliefs concerning patient involvement, the way in which healthcare professionals operate as a team, and the underlying culture. CONCLUSION:Patients appear to have more access to paper-based records than electronic equivalents. However, to develop interventions to increase patient involvement with medication safety behaviours, a wider range of factors needs to be considered